Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	146.65	131.54	123.65	141.52	203.52
Short-Term Investments	-	138.37	199.46	202.75	296.33
Cash & Short-Term Investments	146.65	269.91	323.11	344.27	499.85
Cash Growth	-45.67%	-16.46%	-6.15%	-31.12%	24.31%
Accounts Receivable	15.18	16.27	10.19	5.15	0.27
Other Current Assets	2.07	3.14	7.53	7.34	7.2
Total Current Assets	163.9	289.32	340.83	356.75	507.31
Net Property, Plant & Equipment	19.66	47.05	45.71	59.22	43.29
Long-Term Investments	-	-	104.02	93.1	120.07
Other Long-Term Assets	2.98	5.22	8.59	5.25	6.81
Total Assets	186.53	341.59	499.15	514.32	677.48
Accounts Payable	2.61	5.49	8.27	9.51	5.05
Accrued Expenses	32.61	45.86	34.56	31.3	20.19
Current Portion of Long-Term Debt	5	5	-	-	-
Current Portion of Leases	6.03	14.65	12.16	11.08	10.31
Unearned Revenue	-	6.22	8.22	8.22	11.33
Total Current Liabilities	46.25	77.23	63.22	60.11	46.88
Long-Term Debt	53.61	52.43	-	-	-
Long-Term Leases	12.07	20.38	24.37	32.86	16.07
Other Long-Term Liabilities	47.32	57.28	62.47	60.67	60.89
Total Long-Term Liabilities	113	130.09	86.84	93.53	76.96
Total Liabilities	159.25	207.32	150.06	153.64	123.84
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,656	1,602	1,580	1,442	1,412
Accumulated Other Comprehensive Income	-	0.27	0.2	-3.6	-0.49
Retained Earnings	-1,629	-1,468	-1,231	-1,078	-857.7
Shareholders' Equity	27.29	134.27	349.1	360.68	553.64
Total Liabilities & Equity	186.53	341.59	499.15	514.32	677.48
Total Debt	76.71	92.47	36.54	43.95	26.38
Net Cash (Debt)	69.94	177.45	286.58	300.33	473.47
Net Cash Growth	-60.59%	-38.08%	-4.58%	-36.57%	25.93%
Net Cash Per Share	0.79	2.15	3.77	4.37	7.00
Book Value	27.29	134.27	349.1	360.68	553.64
Book Value Per Share	0.31	1.63	4.60	5.25	8.19
Tangible Book Value	27.29	134.27	349.1	360.68	553.64
Tangible Book Value Per Share	0.31	1.63	4.60	5.25	8.19

Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q